The Abreu btt 700 System sensor is a new patient monitoring device, approved by the US Food and Drug Administration for placement on the skin and to be used during surgical procedures, recovery room, intensive care and general patient monitoring.

The Abreu btt 700 System is the continuous and noninvasive device that measures temperature on the skin surface of the body with the highest thermoconductivity, and also measures the fat-free skin that overlies the Brain Temperature Tunnel (BTT), btt Corp said.

BTT CEO Rick Foreman said that they are very excited that medical professionals and researchers will now have access to the first product in history that enables temperature to be continuously monitored on the only truly thermoconductive skin in the body.

“By uniquely harnessing the best of biology to create the best of technology, we will enable clinicians to escape their dependence on invasive thermometry and surface measurements across thermal barriers,” Foreman said.